Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP433521.RAFGQih9_jgWddMucAemVRFuaN2p-gQstzA9nVr3Rfvw4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP433521.RAFGQih9_jgWddMucAemVRFuaN2p-gQstzA9nVr3Rfvw4130_assertion type Assertion NP433521.RAFGQih9_jgWddMucAemVRFuaN2p-gQstzA9nVr3Rfvw4130_head.
- NP433521.RAFGQih9_jgWddMucAemVRFuaN2p-gQstzA9nVr3Rfvw4130_assertion description "[In this study we show that ROS1 is abnormally activated in the CD34+ compartment of approximately 70% of CMML patients resulting in the activation of the Erk/Akt pathways through the Grb2/SOS complex thus revealing a central oncogenic role for ROS1 in CMML which might represent a molecular target.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP433521.RAFGQih9_jgWddMucAemVRFuaN2p-gQstzA9nVr3Rfvw4130_provenance.
- NP433521.RAFGQih9_jgWddMucAemVRFuaN2p-gQstzA9nVr3Rfvw4130_assertion evidence source_evidence_literature NP433521.RAFGQih9_jgWddMucAemVRFuaN2p-gQstzA9nVr3Rfvw4130_provenance.
- NP433521.RAFGQih9_jgWddMucAemVRFuaN2p-gQstzA9nVr3Rfvw4130_assertion SIO_000772 23415111 NP433521.RAFGQih9_jgWddMucAemVRFuaN2p-gQstzA9nVr3Rfvw4130_provenance.
- NP433521.RAFGQih9_jgWddMucAemVRFuaN2p-gQstzA9nVr3Rfvw4130_assertion wasDerivedFrom befree-20150227 NP433521.RAFGQih9_jgWddMucAemVRFuaN2p-gQstzA9nVr3Rfvw4130_provenance.
- NP433521.RAFGQih9_jgWddMucAemVRFuaN2p-gQstzA9nVr3Rfvw4130_assertion wasGeneratedBy ECO_0000203 NP433521.RAFGQih9_jgWddMucAemVRFuaN2p-gQstzA9nVr3Rfvw4130_provenance.